2013
DOI: 10.1089/scd.2012.0633
|View full text |Cite
|
Sign up to set email alerts
|

Cell and Gene Therapy in Alzheimer's Disease

Abstract: Alzheimer's disease (AD) is a progressive neurological disorder characterized by the aggregation of two proteins, amyloid-β and hyperphosphorylated tau, and by neuronal and synaptic loss. Although some drugs have been shown to slow the progression of the disease, at present no treatment has been developed that can stop or reverse the progression of the pathology. Recently, new therapeutic strategies have been proposed for the treatment of the disease. Among these, the development of stem cells and gene-modifie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
26
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 33 publications
(26 citation statements)
references
References 92 publications
0
26
0
Order By: Relevance
“…Several potential approaches for AD treatment such as cell and gene therapies are currently under investigation; however, a great number of compounds for AD failed to reach the goal [36].…”
Section: Discussionmentioning
confidence: 99%
“…Several potential approaches for AD treatment such as cell and gene therapies are currently under investigation; however, a great number of compounds for AD failed to reach the goal [36].…”
Section: Discussionmentioning
confidence: 99%
“…Conse-51 quences are progressive cognitive decline and behavioral abnormalities 52 (Giuliani et al, 2014a;Ittner and Götz, 2011;Sperling et al, 2013;Tayeb 53 et al, 2012). In addition to neuroprotective approaches for AD treat- Galimberti et al, 2013;Glat and Offen, 2013;Iqbal and Grundke-Iqbal, 58 2011; Lilja et al, 2013;Tayeb et al, 2012;Wang et al, 2010).…”
mentioning
confidence: 99%
“…Stem cells provide an opportunity for therapeutics to cure neurological disorders or injuries, such as Parkinson's and Alzheimer's diseases17181920. Parkinson's disease is resulted from the loss of dopaminergic neurons in the substantia nigra1821.…”
mentioning
confidence: 99%
“…Stem cells express glial-cell-line-derived neurotrophic factor, which has been shown to improve the survival and function of dopaminergic neurons that may be one approach to stop the death of dopaminergic neurons2022. Furthermore, stem cells can generate cholinergic neurons to improve the cognitive function of Alzheimer's disease patients1819.…”
mentioning
confidence: 99%